Dr. Port is the co-founder and Chairman of the Board for RF Surgical Systems. Dr. Port currently resides as a Professor of Cardiothoracic Surgery and an Associate Attending Surgeon in the Division of Thoracic Surgery at New York Presbyterian-Weill Cornell Medical Center within the Department of Cardiothoracic Surgery. He is a member of the American College of Surgeons, American Society of Clinical Oncology, American Association for Cancer Research, American Association of Thoracic Surgery, and Society for Thoracic Surgeons. Dr. Port earned his MD and also finished his general surgery residency at the New York University School of Medicine and completed his cardiothoracic surgical training at Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center.
Steve BastaBoard Member
In October 2011 Mr. Basta was appointed CEO of AlterG, a rehabilitation and fitness products company providing revolutionary technology to improve mobility, including the AlterG Anti-Gravity Treadmill and the AlterG Bionic Leg. Before joining AlterG, he led several emerging biopharmaceutical and medical device companies. From 2002 through 2010, he was CEO of BioForm Medical, Inc., leading the company through global commercialization of advanced aesthetics technologies; including an initial public offering as well as an acquisition by Merz, a German pharmaceutical company. Following the acquisition by Merz, he served as the global business unit leader for Merz Aesthetics, Inc. from 2010 through 2011. Prior to this he was President and CEO of Gliatech, Inc., VP Business Development and Chief Financial Officer of Creative BioMolecules, Inc., and Executive Director of Product Development for The Immune Response Corporation. Mr. Basta began his career in investment banking with Dillon, Read and Co. Inc. Mr. Basta holds a BA in BioMedical Engineering from The Johns Hopkins University and received his Master of Management degree from the Kellogg Graduate School of Business at Northwestern University.
Vickie CappsBoard Member
Mrs. Capps has more than 20 years of experience as a CFO and audit professional in the life sciences industry, having recently served an 11-year tenure as Executive Vice president, CFO and Treasurer for DJO Global Inc., a global provider of medical devices. Earlier in her career, Mrs. Capps spent 10 years with Ernst & Young as a Senior Audit & Accounting professional. She also currently serves on the Senior Advisory Board of Consonance Capital Partners, the Board of Directors of biopharmaceutical company Otonomy, Inc. and previously served on the Board of the publicly traded medical device company SenoRx until its acquisition by C. R. Bard, Inc. Mrs. Capps received her BA degree in Business Administration/Accounting from San Diego State University and is a Certified Public Accountant.
Doug CarlisleBoard Member
Mr. Carlisle has over 30 years of Venture Capital experience and has been with Menlo Ventures since 1982. Throughout his career, Mr. Carlisle has focused on investments within the information technology sector, championing many company funding's which have resulted in successful acquisitions and mergers. In addition to RF Surgical Systems, Mr. Carlisle's current investment portfolio and board seats include: Ansible, Cellfire, Check, LiveOps, Lytx, nLight Photonics and Vidyo. Mr. Carlisle holds a B.S. in Electrical Engineering & Computer science from University of California, Berkeley and a JD/MBA from Stanford University.
Josh BaltzellBoard Member
Mr. Baltzell serves as a Managing Director with Split Rock Partners' Healthcare Investment Team. Prior to joining Split Rock Partners, Mr. Baltzell served as a Principal with St. Paul Venture Capital's healthcare team, which he joined in 2002. Prior to St. Paul Venture Capital, Mr. Baltzell held the position of Vice President with Piper Jaffray's Healthcare Investment Banking group. Prior to joining Piper Jaffray, Mr. Baltzell spent more than seven years in various marketing and business development positions in the medical device industry including Vice President, Marketing and Business Development for a medical device start-up and Group Product Manager - Emerging Technologies for SCIMED/Boston Scientific. Mr. Baltzell graduated from St. Olaf College and has an MBA from the University of Minnesota's Carlson School of Management.
Chris OwensBoard Member
Mr. Owens has over 20 years of medical device experience holding senior-level executive positions in both commercial and technical areas. He is currently the President & CEO of Gynesonics Inc. Gynesonics is a privately held mid-late stage medical device company, dedicated to improving the lives of women suffering from symptomatic uterine fibroids through the use of innovative, minimally invasive technologies. Prior to joining Gynesonics, Chris was the President & CEO of IDEV Technologies from 2008-2013. IDEV was a privately held medical device company focused on the peripheral vascular market, which was acquired by Abbott in 2013. From 2005-2008, he served as Vice President of Worldwide Marketing for MicroVention, a startup medical device company in the neurovascular space that was purchased by Terumo Corporation. From 2003-2005, he was the Vice President of Global Research and Development for the Surgical Division of Bausch & Lomb. Mr. Owens earned a bachelor's degree and a master's degree in Plastics Engineering from the University of Massachusetts, Lowell, and a MBA from the University of Phoenix.